Akèy › Rezistans Insilin › Tennessee
Etid klinik pou Rezistans Insilin nan Tennessee
5 etid pou Rezistans Insilin ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
Metabolic Effects of Angiotensin-(1-7)
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou May 22, 2026 · NCT02646475Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 2
Laj 21 a 85 · Tout sèks · Mizajou May 6, 2026 · NCT04984226Cardiometabolic Disease and Substrate Metabolism
- University of Tennessee Graduate School of Medicine, Knoxville
Ap rekriteEtid obsèvasyon
Laj 18 a 45 · Fanm · Mizajou May 4, 2026 · NCT07565727Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05455619Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Dec 23, 2025 · NCT06609356Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.